References
1. Burkhardt B, Zimmermann M, Oschiles I et al. The impact of age and
gender on biology, clinical features and treatment outcomes of
non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 2005;
131: 39-49.
2. Brugières L, Le Deley MC, Rosolen A et al. Impact of the methotrexate
administration dose on the need for intrathecal treatment in children
and adolescents with anaplastic large-cell lymphoma: Results of a
randomized trial of the EICNHL Group. J Clin Oncol 2009; 27: 897-903.
3. Le Deley MC, Rosolen A, Williams DM et al. Vinblastine in children
and adolescents with high-risk anaplastic large-cell lymphoma: Results
of the randomized ALCL99-vinblastine trail. J Clin Oncol 2010; 28:
3987-3993.
4. Brugières L, Pacquement H, Le Deley MC et al. Single-drug vinblastine
as salvage treatment for refractory or relapsed anaplastic large-cell
lymphoma: a report from the French Society of Pediatric Oncology. J Clin
Oncol 2009; 27: 5056-5061.
5 Emanuela M, Giuseppe C, Sonia C et al. Vinca alkaloids and analogues
as anti-cancer agents: looking back, peering ahead. Bioorg Med Chem Lett
2018; 28: 2816-2826.
6. Devizzi L, Santoro A, Bonfante V et al. Vinorelbine: An active agent
for the management of patients with heavily pretreated Hodgkin disease.
Ann Oncol 1994; 5: 817-820.
7. Kuttesch JF, Krailo MD, Madden T et al. Phase II evaluation of
intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric
malignancies. A Children’s oncology group study. Pediatr Blood Cancer
2009; 53: 590-593.
8. Subspecialty Group of Hematology, the Society of Pediatrics, Chinese
Medical Association, Pediatric Oncology Committee, Chinese Anticancer
Association, Editorial Board of Chinese Journal of Pediatrics.
Recommendation for pediatric non-Hodgkin’s lymphoma [in Chinese].
Zhonghua Er Ke Za Zhi 2011; 49: 186-192.
9. Brugières L, Quartier P, Le Deley MC et al. Relapses of childhood
anaplastic large-cell lymphoma: Treatment results in a series of 41
children-a report from the French Society of Pediatric Oncology. Ann
Oncol 2009; 11: 53-58.
10. Lymphoma Study Group, Subspecialty Group of Hematology, the Society
of Pediatrics, Chinese Medical Association; Lymphoma Study Group,
Committee of Pediatrics, Chinese Anti-Cancer Association. Diagnosis and
Treatment of Anaplastic Large-Cell Lymphoma in Children and Adolescents:
A Retrospective Multicenter Survey Study [in Chinese]. Zhonghua Er
Ke Za Zhi 2017; 55: 194-199.
11. Shi Y, Chen L, Li J et al. Prognostic and predictive value of
pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients
treated with adjuvant chemotherapy. Tumor Biol 2011; 32: 381-390.